aTyr Pharma Stock (NASDAQ: LIFE) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 582.857K |
Day Range | - - - |
52 Wk Range | 1.080 - 2.700 |
Market Cap | $117.319M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 0.78% |
Days to Cover | 1.07 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of aTyr Pharma (NASDAQ: LIFE) through any online brokerage.
Other companies in aTyr Pharma’s space includes: Molecular Partners (NASDAQ:MOLN), Cellectar Biosciences (NASDAQ:CLRB), Curis (NASDAQ:CRIS), Armata Pharmaceuticals (AMEX:ARMP) and Gritstone Bio (NASDAQ:GRTS).
The latest price target for aTyr Pharma (NASDAQ: LIFE) was reported by HC Wainwright & Co. on Friday, May 3, 2024. The analyst firm set a price target for 35.00 expecting LIFE to rise to within 12 months (a possible 1958.82% upside). 11 analyst firms have reported ratings in the last year.
The stock price for aTyr Pharma (NASDAQ: LIFE) is $1.7 last updated May 7, 2024 at 7:32 PM EDT.
There are no upcoming dividends for aTyr Pharma.
aTyr Pharma’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for aTyr Pharma.
aTyr Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.